nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextrothyroxine—SLCO4C1—Methotrexate—urinary bladder cancer	0.32	0.518	CbGbCtD
Dextrothyroxine—SLCO1C1—Methotrexate—urinary bladder cancer	0.225	0.364	CbGbCtD
Dextrothyroxine—SLCO1B1—Methotrexate—urinary bladder cancer	0.0731	0.118	CbGbCtD
Dextrothyroxine—THRB—prostate gland—urinary bladder cancer	0.00836	0.0612	CbGeAlD
Dextrothyroxine—THRA—prostate gland—urinary bladder cancer	0.00836	0.0612	CbGeAlD
Dextrothyroxine—SLCO1B1—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.00748	0.0822	CbGpPWpGaD
Dextrothyroxine—SLCO4C1—seminal vesicle—urinary bladder cancer	0.00738	0.054	CbGeAlD
Dextrothyroxine—SLC7A5—prostate gland—urinary bladder cancer	0.00638	0.0467	CbGeAlD
Dextrothyroxine—SLCO4C1—renal system—urinary bladder cancer	0.00595	0.0435	CbGeAlD
Dextrothyroxine—THRA—renal system—urinary bladder cancer	0.0057	0.0417	CbGeAlD
Dextrothyroxine—THRB—renal system—urinary bladder cancer	0.0057	0.0417	CbGeAlD
Dextrothyroxine—SLCO4A1—prostate gland—urinary bladder cancer	0.00557	0.0408	CbGeAlD
Dextrothyroxine—SLC7A5—seminal vesicle—urinary bladder cancer	0.0054	0.0395	CbGeAlD
Dextrothyroxine—TPO—Hematopoietic Stem Cell Differentiation—CSF3—urinary bladder cancer	0.00489	0.0537	CbGpPWpGaD
Dextrothyroxine—SLCO1C1—renal system—urinary bladder cancer	0.00474	0.0347	CbGeAlD
Dextrothyroxine—SLCO4A1—seminal vesicle—urinary bladder cancer	0.00471	0.0345	CbGeAlD
Dextrothyroxine—SLC7A5—epithelium—urinary bladder cancer	0.00469	0.0343	CbGeAlD
Dextrothyroxine—THRA—female reproductive system—urinary bladder cancer	0.00457	0.0334	CbGeAlD
Dextrothyroxine—THRB—female reproductive system—urinary bladder cancer	0.00457	0.0334	CbGeAlD
Dextrothyroxine—SLC7A5—smooth muscle tissue—urinary bladder cancer	0.00452	0.0331	CbGeAlD
Dextrothyroxine—SLCO4C1—vagina—urinary bladder cancer	0.00431	0.0315	CbGeAlD
Dextrothyroxine—SLC7A5—urethra—urinary bladder cancer	0.00427	0.0313	CbGeAlD
Dextrothyroxine—THRB—vagina—urinary bladder cancer	0.00413	0.0302	CbGeAlD
Dextrothyroxine—SLCO4A1—renal system—urinary bladder cancer	0.0038	0.0278	CbGeAlD
Dextrothyroxine—THRA—Endochondral Ossification—HDAC4—urinary bladder cancer	0.00378	0.0416	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—urethra—urinary bladder cancer	0.00373	0.0273	CbGeAlD
Dextrothyroxine—SLC7A5—female reproductive system—urinary bladder cancer	0.00348	0.0255	CbGeAlD
Dextrothyroxine—SLCO1B1—renal system—urinary bladder cancer	0.00334	0.0245	CbGeAlD
Dextrothyroxine—SLC7A5—vagina—urinary bladder cancer	0.00315	0.0231	CbGeAlD
Dextrothyroxine—SLCO4A1—female reproductive system—urinary bladder cancer	0.00304	0.0223	CbGeAlD
Dextrothyroxine—THRA—Nuclear Receptors—ESR2—urinary bladder cancer	0.00278	0.0306	CbGpPWpGaD
Dextrothyroxine—THRB—Nuclear Receptors—ESR2—urinary bladder cancer	0.00278	0.0306	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—vagina—urinary bladder cancer	0.00275	0.0201	CbGeAlD
Dextrothyroxine—SLCO1B1—female reproductive system—urinary bladder cancer	0.00268	0.0196	CbGeAlD
Dextrothyroxine—THRB—lymph node—urinary bladder cancer	0.00267	0.0195	CbGeAlD
Dextrothyroxine—THRA—lymph node—urinary bladder cancer	0.00267	0.0195	CbGeAlD
Dextrothyroxine—TPO—Amino acid and derivative metabolism—GSTZ1—urinary bladder cancer	0.00239	0.0263	CbGpPWpGaD
Dextrothyroxine—SLCO1C1—lymph node—urinary bladder cancer	0.00222	0.0162	CbGeAlD
Dextrothyroxine—THRA—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.0022	0.0242	CbGpPWpGaD
Dextrothyroxine—THRB—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.0022	0.0242	CbGpPWpGaD
Dextrothyroxine—THRB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—urinary bladder cancer	0.00208	0.0229	CbGpPWpGaD
Dextrothyroxine—THRA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—urinary bladder cancer	0.00208	0.0229	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—NQO1—urinary bladder cancer	0.00204	0.0225	CbGpPWpGaD
Dextrothyroxine—SLC7A5—lymph node—urinary bladder cancer	0.00204	0.0149	CbGeAlD
Dextrothyroxine—SLCO4A1—lymph node—urinary bladder cancer	0.00178	0.013	CbGeAlD
Dextrothyroxine—THRB—Nuclear Receptors—ESR1—urinary bladder cancer	0.00169	0.0185	CbGpPWpGaD
Dextrothyroxine—THRA—Nuclear Receptors—ESR1—urinary bladder cancer	0.00169	0.0185	CbGpPWpGaD
Dextrothyroxine—SLCO4C1—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00158	0.0174	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00158	0.0174	CbGpPWpGaD
Dextrothyroxine—THRA—Nuclear Receptors—PPARG—urinary bladder cancer	0.00154	0.0169	CbGpPWpGaD
Dextrothyroxine—THRB—Nuclear Receptors—PPARG—urinary bladder cancer	0.00154	0.0169	CbGpPWpGaD
Dextrothyroxine—SLC7A5—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00145	0.0159	CbGpPWpGaD
Dextrothyroxine—THRA—Nuclear Receptor transcription pathway—ESR1—urinary bladder cancer	0.00133	0.0147	CbGpPWpGaD
Dextrothyroxine—THRB—Nuclear Receptor transcription pathway—ESR1—urinary bladder cancer	0.00133	0.0147	CbGpPWpGaD
Dextrothyroxine—SLCO1C1—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00133	0.0146	CbGpPWpGaD
Dextrothyroxine—TPO—Differentiation Pathway—IGF1—urinary bladder cancer	0.00124	0.0137	CbGpPWpGaD
Dextrothyroxine—THRB—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.00122	0.0134	CbGpPWpGaD
Dextrothyroxine—THRA—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.00122	0.0134	CbGpPWpGaD
Dextrothyroxine—THRA—Endochondral Ossification—PLAU—urinary bladder cancer	0.00118	0.013	CbGpPWpGaD
Dextrothyroxine—THRA—Endochondral Ossification—FGFR3—urinary bladder cancer	0.00114	0.0126	CbGpPWpGaD
Dextrothyroxine—THRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—urinary bladder cancer	0.00111	0.0122	CbGpPWpGaD
Dextrothyroxine—THRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—urinary bladder cancer	0.00111	0.0122	CbGpPWpGaD
Dextrothyroxine—Cardiac failure—Fluorouracil—urinary bladder cancer	0.0011	0.00713	CcSEcCtD
Dextrothyroxine—Nausea—Valrubicin—urinary bladder cancer	0.00109	0.00708	CcSEcCtD
Dextrothyroxine—Fatigue—Mitomycin—urinary bladder cancer	0.00109	0.00708	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00105	0.00677	CcSEcCtD
Dextrothyroxine—Cardiac failure congestive—Etoposide—urinary bladder cancer	0.00103	0.00666	CcSEcCtD
Dextrothyroxine—Irritability—Fluorouracil—urinary bladder cancer	0.00102	0.00664	CcSEcCtD
Dextrothyroxine—Cardiac arrest—Fluorouracil—urinary bladder cancer	0.00102	0.00661	CcSEcCtD
Dextrothyroxine—Body temperature increased—Mitomycin—urinary bladder cancer	0.001	0.0065	CcSEcCtD
Dextrothyroxine—Irritability—Cisplatin—urinary bladder cancer	0.000972	0.00629	CcSEcCtD
Dextrothyroxine—THRA—Endochondral Ossification—IGF1—urinary bladder cancer	0.000962	0.0106	CbGpPWpGaD
Dextrothyroxine—Cardiac failure—Etoposide—urinary bladder cancer	0.000956	0.00619	CcSEcCtD
Dextrothyroxine—Muscular weakness—Fluorouracil—urinary bladder cancer	0.000947	0.00613	CcSEcCtD
Dextrothyroxine—Dehydration—Cisplatin—urinary bladder cancer	0.000947	0.00613	CcSEcCtD
Dextrothyroxine—Dysphagia—Fluorouracil—urinary bladder cancer	0.000928	0.00601	CcSEcCtD
Dextrothyroxine—Asthenia—Mitomycin—urinary bladder cancer	0.00091	0.0059	CcSEcCtD
Dextrothyroxine—Angina pectoris—Fluorouracil—urinary bladder cancer	0.000904	0.00585	CcSEcCtD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.000899	0.00988	CbGpPWpGaD
Dextrothyroxine—Cardiac arrest—Etoposide—urinary bladder cancer	0.000887	0.00574	CcSEcCtD
Dextrothyroxine—Diarrhoea—Mitomycin—urinary bladder cancer	0.000868	0.00562	CcSEcCtD
Dextrothyroxine—Sweating increased—Cisplatin—urinary bladder cancer	0.000857	0.00555	CcSEcCtD
Dextrothyroxine—Acute coronary syndrome—Gemcitabine—urinary bladder cancer	0.00083	0.00537	CcSEcCtD
Dextrothyroxine—Myocardial infarction—Gemcitabine—urinary bladder cancer	0.000825	0.00534	CcSEcCtD
Dextrothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000819	0.009	CbGpPWpGaD
Dextrothyroxine—Acute coronary syndrome—Fluorouracil—urinary bladder cancer	0.000816	0.00528	CcSEcCtD
Dextrothyroxine—Myocardial infarction—Fluorouracil—urinary bladder cancer	0.000811	0.00525	CcSEcCtD
Dextrothyroxine—Sweating—Gemcitabine—urinary bladder cancer	0.000807	0.00523	CcSEcCtD
Dextrothyroxine—Vomiting—Mitomycin—urinary bladder cancer	0.000807	0.00522	CcSEcCtD
Dextrothyroxine—Dysphagia—Etoposide—urinary bladder cancer	0.000806	0.00522	CcSEcCtD
Dextrothyroxine—SLCO4A1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000805	0.00885	CbGpPWpGaD
Dextrothyroxine—SLCO4C1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000805	0.00885	CbGpPWpGaD
Dextrothyroxine—Arrhythmia—Thiotepa—urinary bladder cancer	0.000802	0.0052	CcSEcCtD
Dextrothyroxine—TPO—Amino acid and derivative metabolism—NQO1—urinary bladder cancer	0.000801	0.00881	CbGpPWpGaD
Dextrothyroxine—Rash—Mitomycin—urinary bladder cancer	0.0008	0.00518	CcSEcCtD
Dextrothyroxine—Dermatitis—Mitomycin—urinary bladder cancer	0.000799	0.00518	CcSEcCtD
Dextrothyroxine—Headache—Mitomycin—urinary bladder cancer	0.000795	0.00515	CcSEcCtD
Dextrothyroxine—Alopecia—Thiotepa—urinary bladder cancer	0.000794	0.00514	CcSEcCtD
Dextrothyroxine—Sweating increased—Etoposide—urinary bladder cancer	0.000785	0.00508	CcSEcCtD
Dextrothyroxine—Acute coronary syndrome—Cisplatin—urinary bladder cancer	0.000773	0.00501	CcSEcCtD
Dextrothyroxine—Myocardial infarction—Cisplatin—urinary bladder cancer	0.000769	0.00498	CcSEcCtD
Dextrothyroxine—Tension—Thiotepa—urinary bladder cancer	0.000767	0.00497	CcSEcCtD
Dextrothyroxine—Nervousness—Thiotepa—urinary bladder cancer	0.000759	0.00492	CcSEcCtD
Dextrothyroxine—Nausea—Mitomycin—urinary bladder cancer	0.000754	0.00488	CcSEcCtD
Dextrothyroxine—SLC7A5—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000736	0.00809	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000735	0.00808	CbGpPWpGaD
Dextrothyroxine—Agitation—Thiotepa—urinary bladder cancer	0.000718	0.00465	CcSEcCtD
Dextrothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000714	0.00785	CbGpPWpGaD
Dextrothyroxine—Acute coronary syndrome—Etoposide—urinary bladder cancer	0.000708	0.00459	CcSEcCtD
Dextrothyroxine—Myocardial infarction—Etoposide—urinary bladder cancer	0.000704	0.00456	CcSEcCtD
Dextrothyroxine—Coma—Methotrexate—urinary bladder cancer	0.000703	0.00455	CcSEcCtD
Dextrothyroxine—THRA—Endochondral Ossification—MMP9—urinary bladder cancer	0.0007	0.00769	CbGpPWpGaD
Dextrothyroxine—Convulsion—Thiotepa—urinary bladder cancer	0.000677	0.00439	CcSEcCtD
Dextrothyroxine—Arrhythmia—Gemcitabine—urinary bladder cancer	0.000675	0.00437	CcSEcCtD
Dextrothyroxine—SLCO1C1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000674	0.00741	CbGpPWpGaD
Dextrothyroxine—Alopecia—Gemcitabine—urinary bladder cancer	0.000668	0.00432	CcSEcCtD
Dextrothyroxine—Arthralgia—Thiotepa—urinary bladder cancer	0.000666	0.00431	CcSEcCtD
Dextrothyroxine—Arrhythmia—Fluorouracil—urinary bladder cancer	0.000664	0.0043	CcSEcCtD
Dextrothyroxine—Anxiety—Thiotepa—urinary bladder cancer	0.000663	0.0043	CcSEcCtD
Dextrothyroxine—Coma—Epirubicin—urinary bladder cancer	0.000658	0.00426	CcSEcCtD
Dextrothyroxine—Alopecia—Fluorouracil—urinary bladder cancer	0.000656	0.00425	CcSEcCtD
Dextrothyroxine—Flushing—Cisplatin—urinary bladder cancer	0.000654	0.00423	CcSEcCtD
Dextrothyroxine—Confusional state—Thiotepa—urinary bladder cancer	0.000643	0.00417	CcSEcCtD
Dextrothyroxine—Arrhythmia—Cisplatin—urinary bladder cancer	0.000629	0.00407	CcSEcCtD
Dextrothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000626	0.00688	CbGpPWpGaD
Dextrothyroxine—Tachycardia—Thiotepa—urinary bladder cancer	0.000623	0.00403	CcSEcCtD
Dextrothyroxine—Alopecia—Cisplatin—urinary bladder cancer	0.000622	0.00403	CcSEcCtD
Dextrothyroxine—Coma—Doxorubicin—urinary bladder cancer	0.000609	0.00394	CcSEcCtD
Dextrothyroxine—Flushing—Etoposide—urinary bladder cancer	0.000599	0.00388	CcSEcCtD
Dextrothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000596	0.00656	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000582	0.0064	CbGpPWpGaD
Dextrothyroxine—SLCO4C1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000582	0.0064	CbGpPWpGaD
Dextrothyroxine—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.000581	0.00376	CcSEcCtD
Dextrothyroxine—Cardiac failure congestive—Epirubicin—urinary bladder cancer	0.000576	0.00373	CcSEcCtD
Dextrothyroxine—Tremor—Cisplatin—urinary bladder cancer	0.000574	0.00372	CcSEcCtD
Dextrothyroxine—Alopecia—Etoposide—urinary bladder cancer	0.00057	0.00369	CcSEcCtD
Dextrothyroxine—Convulsion—Fluorouracil—urinary bladder cancer	0.00056	0.00363	CcSEcCtD
Dextrothyroxine—Arthralgia—Gemcitabine—urinary bladder cancer	0.00056	0.00363	CcSEcCtD
Dextrothyroxine—Increased appetite—Epirubicin—urinary bladder cancer	0.000556	0.0036	CcSEcCtD
Dextrothyroxine—Fatigue—Thiotepa—urinary bladder cancer	0.00055	0.00356	CcSEcCtD
Dextrothyroxine—Hypoglycaemia—Epirubicin—urinary bladder cancer	0.000536	0.00347	CcSEcCtD
Dextrothyroxine—Cardiac failure—Epirubicin—urinary bladder cancer	0.000536	0.00347	CcSEcCtD
Dextrothyroxine—Cardiac failure congestive—Doxorubicin—urinary bladder cancer	0.000533	0.00345	CcSEcCtD
Dextrothyroxine—Irritability—Methotrexate—urinary bladder cancer	0.000533	0.00345	CcSEcCtD
Dextrothyroxine—SLC7A5—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000532	0.00585	CbGpPWpGaD
Dextrothyroxine—Confusional state—Fluorouracil—urinary bladder cancer	0.000532	0.00345	CcSEcCtD
Dextrothyroxine—Convulsion—Cisplatin—urinary bladder cancer	0.000531	0.00344	CcSEcCtD
Dextrothyroxine—Mood swings—Methotrexate—urinary bladder cancer	0.000529	0.00343	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000526	0.00341	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000522	0.00338	CcSEcCtD
Dextrothyroxine—Anxiety—Cisplatin—urinary bladder cancer	0.00052	0.00337	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000519	0.00336	CcSEcCtD
Dextrothyroxine—Tachycardia—Fluorouracil—urinary bladder cancer	0.000515	0.00334	CcSEcCtD
Dextrothyroxine—Increased appetite—Doxorubicin—urinary bladder cancer	0.000515	0.00333	CcSEcCtD
Dextrothyroxine—Affect lability—Epirubicin—urinary bladder cancer	0.000515	0.00333	CcSEcCtD
Dextrothyroxine—Urticaria—Thiotepa—urinary bladder cancer	0.000507	0.00328	CcSEcCtD
Dextrothyroxine—SLCO1B1—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000505	0.00555	CbGpPWpGaD
Dextrothyroxine—Abdominal pain—Thiotepa—urinary bladder cancer	0.000504	0.00327	CcSEcCtD
Dextrothyroxine—Body temperature increased—Thiotepa—urinary bladder cancer	0.000504	0.00327	CcSEcCtD
Dextrothyroxine—Cardiac arrest—Epirubicin—urinary bladder cancer	0.000497	0.00322	CcSEcCtD
Dextrothyroxine—Hypoglycaemia—Doxorubicin—urinary bladder cancer	0.000496	0.00321	CcSEcCtD
Dextrothyroxine—Cardiac failure—Doxorubicin—urinary bladder cancer	0.000496	0.00321	CcSEcCtD
Dextrothyroxine—Mood swings—Epirubicin—urinary bladder cancer	0.000495	0.00321	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000489	0.00317	CcSEcCtD
Dextrothyroxine—Tachycardia—Cisplatin—urinary bladder cancer	0.000488	0.00316	CcSEcCtD
Dextrothyroxine—SLCO1C1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000488	0.00536	CbGpPWpGaD
Dextrothyroxine—Convulsion—Etoposide—urinary bladder cancer	0.000487	0.00315	CcSEcCtD
Dextrothyroxine—Dehydration—Epirubicin—urinary bladder cancer	0.000486	0.00315	CcSEcCtD
Dextrothyroxine—Insomnia—Gemcitabine—urinary bladder cancer	0.000485	0.00314	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000484	0.00313	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000481	0.00311	CcSEcCtD
Dextrothyroxine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000479	0.0031	CcSEcCtD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000478	0.00525	CbGpPWpGaD
Dextrothyroxine—Insomnia—Fluorouracil—urinary bladder cancer	0.000477	0.00309	CcSEcCtD
Dextrothyroxine—Affect lability—Doxorubicin—urinary bladder cancer	0.000476	0.00308	CcSEcCtD
Dextrothyroxine—SLCO4A1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000474	0.00521	CbGpPWpGaD
Dextrothyroxine—SLCO4C1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000474	0.00521	CbGpPWpGaD
Dextrothyroxine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000471	0.00305	CcSEcCtD
Dextrothyroxine—Fatigue—Gemcitabine—urinary bladder cancer	0.000463	0.003	CcSEcCtD
Dextrothyroxine—Confusional state—Etoposide—urinary bladder cancer	0.000462	0.00299	CcSEcCtD
Dextrothyroxine—Muscular weakness—Epirubicin—urinary bladder cancer	0.000461	0.00299	CcSEcCtD
Dextrothyroxine—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.00046	0.00298	CcSEcCtD
Dextrothyroxine—Mood swings—Doxorubicin—urinary bladder cancer	0.000458	0.00297	CcSEcCtD
Dextrothyroxine—Asthenia—Thiotepa—urinary bladder cancer	0.000458	0.00296	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000456	0.00295	CcSEcCtD
Dextrothyroxine—Dysphagia—Epirubicin—urinary bladder cancer	0.000452	0.00293	CcSEcCtD
Dextrothyroxine—Pruritus—Thiotepa—urinary bladder cancer	0.000451	0.00292	CcSEcCtD
Dextrothyroxine—Dehydration—Doxorubicin—urinary bladder cancer	0.00045	0.00291	CcSEcCtD
Dextrothyroxine—Tachycardia—Etoposide—urinary bladder cancer	0.000447	0.0029	CcSEcCtD
Dextrothyroxine—Dyspnoea—Cisplatin—urinary bladder cancer	0.000446	0.00289	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000443	0.00287	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000442	0.00286	CcSEcCtD
Dextrothyroxine—Angina pectoris—Epirubicin—urinary bladder cancer	0.00044	0.00285	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—GSTZ1—urinary bladder cancer	0.00044	0.00483	CbGpPWpGaD
Dextrothyroxine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000437	0.00283	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000435	0.00282	CcSEcCtD
Dextrothyroxine—SLC7A5—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000434	0.00477	CbGpPWpGaD
Dextrothyroxine—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000427	0.00276	CcSEcCtD
Dextrothyroxine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000424	0.00275	CcSEcCtD
Dextrothyroxine—Urticaria—Fluorouracil—urinary bladder cancer	0.000419	0.00272	CcSEcCtD
Dextrothyroxine—Dysphagia—Doxorubicin—urinary bladder cancer	0.000418	0.00271	CcSEcCtD
Dextrothyroxine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000417	0.0027	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—GSTO2—urinary bladder cancer	0.000417	0.00458	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—NAT1—urinary bladder cancer	0.000417	0.00458	CbGpPWpGaD
Dextrothyroxine—Sweating—Methotrexate—urinary bladder cancer	0.000413	0.00267	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000412	0.00267	CcSEcCtD
Dextrothyroxine—Weight decreased—Epirubicin—urinary bladder cancer	0.000409	0.00265	CcSEcCtD
Dextrothyroxine—Dyspnoea—Etoposide—urinary bladder cancer	0.000409	0.00265	CcSEcCtD
Dextrothyroxine—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000407	0.00264	CcSEcCtD
Dextrothyroxine—Vomiting—Thiotepa—urinary bladder cancer	0.000406	0.00263	CcSEcCtD
Dextrothyroxine—Rash—Thiotepa—urinary bladder cancer	0.000402	0.00261	CcSEcCtD
Dextrothyroxine—Dermatitis—Thiotepa—urinary bladder cancer	0.000402	0.0026	CcSEcCtD
Dextrothyroxine—Headache—Thiotepa—urinary bladder cancer	0.0004	0.00259	CcSEcCtD
Dextrothyroxine—SLCO1C1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000397	0.00437	CbGpPWpGaD
Dextrothyroxine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000396	0.00256	CcSEcCtD
Dextrothyroxine—Fatigue—Etoposide—urinary bladder cancer	0.000395	0.00256	CcSEcCtD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—SRC—urinary bladder cancer	0.000387	0.00425	CbGpPWpGaD
Dextrothyroxine—Sweating—Epirubicin—urinary bladder cancer	0.000386	0.0025	CcSEcCtD
Dextrothyroxine—Asthenia—Gemcitabine—urinary bladder cancer	0.000385	0.00249	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—UGT2B7—urinary bladder cancer	0.000381	0.00419	CbGpPWpGaD
Dextrothyroxine—Pruritus—Gemcitabine—urinary bladder cancer	0.00038	0.00246	CcSEcCtD
Dextrothyroxine—THRA—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.00038	0.00417	CbGpPWpGaD
Dextrothyroxine—THRB—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.00038	0.00417	CbGpPWpGaD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000379	0.00417	CbGpPWpGaD
Dextrothyroxine—Nausea—Thiotepa—urinary bladder cancer	0.000379	0.00245	CcSEcCtD
Dextrothyroxine—Weight decreased—Doxorubicin—urinary bladder cancer	0.000378	0.00245	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000378	0.00245	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000375	0.00243	CcSEcCtD
Dextrothyroxine—Pruritus—Fluorouracil—urinary bladder cancer	0.000373	0.00242	CcSEcCtD
Dextrothyroxine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000367	0.00238	CcSEcCtD
Dextrothyroxine—Urticaria—Etoposide—urinary bladder cancer	0.000364	0.00236	CcSEcCtD
Dextrothyroxine—Body temperature increased—Etoposide—urinary bladder cancer	0.000362	0.00235	CcSEcCtD
Dextrothyroxine—Abdominal pain—Etoposide—urinary bladder cancer	0.000362	0.00235	CcSEcCtD
Dextrothyroxine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000361	0.00234	CcSEcCtD
Dextrothyroxine—Asthenia—Cisplatin—urinary bladder cancer	0.000359	0.00232	CcSEcCtD
Dextrothyroxine—Sweating—Doxorubicin—urinary bladder cancer	0.000357	0.00231	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—CYP4B1—urinary bladder cancer	0.000343	0.00377	CbGpPWpGaD
Dextrothyroxine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000342	0.00222	CcSEcCtD
Dextrothyroxine—Alopecia—Methotrexate—urinary bladder cancer	0.000341	0.00221	CcSEcCtD
Dextrothyroxine—Vomiting—Gemcitabine—urinary bladder cancer	0.000341	0.00221	CcSEcCtD
Dextrothyroxine—Rash—Gemcitabine—urinary bladder cancer	0.000338	0.00219	CcSEcCtD
Dextrothyroxine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000338	0.00219	CcSEcCtD
Dextrothyroxine—Headache—Gemcitabine—urinary bladder cancer	0.000336	0.00218	CcSEcCtD
Dextrothyroxine—Flushing—Epirubicin—urinary bladder cancer	0.000336	0.00217	CcSEcCtD
Dextrothyroxine—Vomiting—Fluorouracil—urinary bladder cancer	0.000336	0.00217	CcSEcCtD
Dextrothyroxine—Rash—Fluorouracil—urinary bladder cancer	0.000333	0.00215	CcSEcCtD
Dextrothyroxine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000332	0.00215	CcSEcCtD
Dextrothyroxine—Headache—Fluorouracil—urinary bladder cancer	0.000331	0.00214	CcSEcCtD
Dextrothyroxine—Asthenia—Etoposide—urinary bladder cancer	0.000329	0.00213	CcSEcCtD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000325	0.00358	CbGpPWpGaD
Dextrothyroxine—Pruritus—Etoposide—urinary bladder cancer	0.000324	0.0021	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—SLC19A1—urinary bladder cancer	0.000324	0.00356	CbGpPWpGaD
Dextrothyroxine—Arrhythmia—Epirubicin—urinary bladder cancer	0.000323	0.00209	CcSEcCtD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—KRAS—urinary bladder cancer	0.00032	0.00352	CbGpPWpGaD
Dextrothyroxine—SLCO4C1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.00032	0.00352	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.00032	0.00352	CbGpPWpGaD
Dextrothyroxine—Alopecia—Epirubicin—urinary bladder cancer	0.00032	0.00207	CcSEcCtD
Dextrothyroxine—Nausea—Gemcitabine—urinary bladder cancer	0.000319	0.00206	CcSEcCtD
Dextrothyroxine—Vomiting—Cisplatin—urinary bladder cancer	0.000318	0.00206	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—PRSS3—urinary bladder cancer	0.000316	0.00347	CbGpPWpGaD
Dextrothyroxine—Rash—Cisplatin—urinary bladder cancer	0.000315	0.00204	CcSEcCtD
Dextrothyroxine—Dermatitis—Cisplatin—urinary bladder cancer	0.000315	0.00204	CcSEcCtD
Dextrothyroxine—Diarrhoea—Etoposide—urinary bladder cancer	0.000314	0.00203	CcSEcCtD
Dextrothyroxine—Nausea—Fluorouracil—urinary bladder cancer	0.000313	0.00203	CcSEcCtD
Dextrothyroxine—Flushing—Doxorubicin—urinary bladder cancer	0.000311	0.00201	CcSEcCtD
Dextrothyroxine—Tension—Epirubicin—urinary bladder cancer	0.000309	0.002	CcSEcCtD
Dextrothyroxine—Nervousness—Epirubicin—urinary bladder cancer	0.000306	0.00198	CcSEcCtD
Dextrothyroxine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000299	0.00194	CcSEcCtD
Dextrothyroxine—Nausea—Cisplatin—urinary bladder cancer	0.000297	0.00192	CcSEcCtD
Dextrothyroxine—Alopecia—Doxorubicin—urinary bladder cancer	0.000296	0.00191	CcSEcCtD
Dextrothyroxine—THRB—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000293	0.00322	CbGpPWpGaD
Dextrothyroxine—THRA—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000293	0.00322	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000293	0.00322	CbGpPWpGaD
Dextrothyroxine—Convulsion—Methotrexate—urinary bladder cancer	0.000291	0.00189	CcSEcCtD
Dextrothyroxine—Vomiting—Etoposide—urinary bladder cancer	0.000291	0.00189	CcSEcCtD
Dextrothyroxine—Agitation—Epirubicin—urinary bladder cancer	0.000289	0.00187	CcSEcCtD
Dextrothyroxine—Rash—Etoposide—urinary bladder cancer	0.000289	0.00187	CcSEcCtD
Dextrothyroxine—Dermatitis—Etoposide—urinary bladder cancer	0.000289	0.00187	CcSEcCtD
Dextrothyroxine—Headache—Etoposide—urinary bladder cancer	0.000287	0.00186	CcSEcCtD
Dextrothyroxine—Arthralgia—Methotrexate—urinary bladder cancer	0.000286	0.00185	CcSEcCtD
Dextrothyroxine—Tension—Doxorubicin—urinary bladder cancer	0.000286	0.00185	CcSEcCtD
Dextrothyroxine—Nervousness—Doxorubicin—urinary bladder cancer	0.000283	0.00183	CcSEcCtD
Dextrothyroxine—Palpitations—Epirubicin—urinary bladder cancer	0.000278	0.0018	CcSEcCtD
Dextrothyroxine—Confusional state—Methotrexate—urinary bladder cancer	0.000277	0.00179	CcSEcCtD
Dextrothyroxine—Convulsion—Epirubicin—urinary bladder cancer	0.000273	0.00177	CcSEcCtD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—HRAS—urinary bladder cancer	0.000272	0.00299	CbGpPWpGaD
Dextrothyroxine—Nausea—Etoposide—urinary bladder cancer	0.000272	0.00176	CcSEcCtD
Dextrothyroxine—SLC7A5—Hemostasis—IFNA2—urinary bladder cancer	0.000271	0.00297	CbGpPWpGaD
Dextrothyroxine—SLCO1C1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000268	0.00295	CbGpPWpGaD
Dextrothyroxine—Arthralgia—Epirubicin—urinary bladder cancer	0.000268	0.00174	CcSEcCtD
Dextrothyroxine—Agitation—Doxorubicin—urinary bladder cancer	0.000268	0.00173	CcSEcCtD
Dextrothyroxine—Anxiety—Epirubicin—urinary bladder cancer	0.000267	0.00173	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000265	0.00172	CcSEcCtD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000264	0.0029	CbGpPWpGaD
Dextrothyroxine—Confusional state—Epirubicin—urinary bladder cancer	0.000259	0.00168	CcSEcCtD
Dextrothyroxine—Palpitations—Doxorubicin—urinary bladder cancer	0.000257	0.00167	CcSEcCtD
Dextrothyroxine—SLCO1B1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000257	0.00282	CbGpPWpGaD
Dextrothyroxine—Shock—Epirubicin—urinary bladder cancer	0.000253	0.00164	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—TYMP—urinary bladder cancer	0.000253	0.00278	CbGpPWpGaD
Dextrothyroxine—Convulsion—Doxorubicin—urinary bladder cancer	0.000252	0.00163	CcSEcCtD
Dextrothyroxine—Tachycardia—Epirubicin—urinary bladder cancer	0.000251	0.00162	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.00025	0.00162	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000248	0.00161	CcSEcCtD
Dextrothyroxine—Insomnia—Methotrexate—urinary bladder cancer	0.000248	0.00161	CcSEcCtD
Dextrothyroxine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000248	0.00161	CcSEcCtD
Dextrothyroxine—Anxiety—Doxorubicin—urinary bladder cancer	0.000247	0.0016	CcSEcCtD
Dextrothyroxine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000245	0.00159	CcSEcCtD
Dextrothyroxine—Confusional state—Doxorubicin—urinary bladder cancer	0.00024	0.00155	CcSEcCtD
Dextrothyroxine—Fatigue—Methotrexate—urinary bladder cancer	0.000237	0.00153	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000234	0.00152	CcSEcCtD
Dextrothyroxine—Shock—Doxorubicin—urinary bladder cancer	0.000234	0.00151	CcSEcCtD
Dextrothyroxine—Insomnia—Epirubicin—urinary bladder cancer	0.000232	0.0015	CcSEcCtD
Dextrothyroxine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000232	0.0015	CcSEcCtD
Dextrothyroxine—THRA—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.00023	0.00253	CbGpPWpGaD
Dextrothyroxine—THRB—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.00023	0.00253	CbGpPWpGaD
Dextrothyroxine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.00023	0.00149	CcSEcCtD
Dextrothyroxine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000229	0.00148	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—NAT2—urinary bladder cancer	0.000228	0.00251	CbGpPWpGaD
Dextrothyroxine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000226	0.00147	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000225	0.00145	CcSEcCtD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000222	0.00244	CbGpPWpGaD
Dextrothyroxine—Fatigue—Epirubicin—urinary bladder cancer	0.000222	0.00143	CcSEcCtD
Dextrothyroxine—Urticaria—Methotrexate—urinary bladder cancer	0.000218	0.00141	CcSEcCtD
Dextrothyroxine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000217	0.00141	CcSEcCtD
Dextrothyroxine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000217	0.00141	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000217	0.0014	CcSEcCtD
Dextrothyroxine—Insomnia—Doxorubicin—urinary bladder cancer	0.000215	0.00139	CcSEcCtD
Dextrothyroxine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000212	0.00137	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000212	0.00137	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00021	0.00136	CcSEcCtD
Dextrothyroxine—THRB—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.00021	0.00231	CbGpPWpGaD
Dextrothyroxine—THRA—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.00021	0.00231	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—SMC1A—urinary bladder cancer	0.00021	0.00231	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—SMC1A—urinary bladder cancer	0.00021	0.00231	CbGpPWpGaD
Dextrothyroxine—Fatigue—Doxorubicin—urinary bladder cancer	0.000205	0.00133	CcSEcCtD
Dextrothyroxine—Urticaria—Epirubicin—urinary bladder cancer	0.000204	0.00132	CcSEcCtD
Dextrothyroxine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000203	0.00132	CcSEcCtD
Dextrothyroxine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000203	0.00132	CcSEcCtD
Dextrothyroxine—THRA—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000202	0.00222	CbGpPWpGaD
Dextrothyroxine—THRB—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000202	0.00222	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—RRM2—urinary bladder cancer	0.000197	0.00217	CbGpPWpGaD
Dextrothyroxine—Asthenia—Methotrexate—urinary bladder cancer	0.000197	0.00128	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000196	0.00127	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000194	0.00126	CcSEcCtD
Dextrothyroxine—Pruritus—Methotrexate—urinary bladder cancer	0.000194	0.00126	CcSEcCtD
Dextrothyroxine—SLC7A5—Hemostasis—PLAU—urinary bladder cancer	0.000192	0.00211	CbGpPWpGaD
Dextrothyroxine—Urticaria—Doxorubicin—urinary bladder cancer	0.000189	0.00122	CcSEcCtD
Dextrothyroxine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000188	0.00122	CcSEcCtD
Dextrothyroxine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000188	0.00122	CcSEcCtD
Dextrothyroxine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000188	0.00122	CcSEcCtD
Dextrothyroxine—SLCO1B1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000186	0.00204	CbGpPWpGaD
Dextrothyroxine—Asthenia—Epirubicin—urinary bladder cancer	0.000184	0.00119	CcSEcCtD
Dextrothyroxine—THRA—Gene Expression—ESR2—urinary bladder cancer	0.000183	0.00201	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—ESR2—urinary bladder cancer	0.000183	0.00201	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—HPGDS—urinary bladder cancer	0.000183	0.00201	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—ENO2—urinary bladder cancer	0.000183	0.00201	CbGpPWpGaD
Dextrothyroxine—Pruritus—Epirubicin—urinary bladder cancer	0.000182	0.00118	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—GSTT1—urinary bladder cancer	0.000177	0.00195	CbGpPWpGaD
Dextrothyroxine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000176	0.00114	CcSEcCtD
Dextrothyroxine—Vomiting—Methotrexate—urinary bladder cancer	0.000175	0.00113	CcSEcCtD
Dextrothyroxine—Rash—Methotrexate—urinary bladder cancer	0.000173	0.00112	CcSEcCtD
Dextrothyroxine—Dermatitis—Methotrexate—urinary bladder cancer	0.000173	0.00112	CcSEcCtD
Dextrothyroxine—Headache—Methotrexate—urinary bladder cancer	0.000172	0.00111	CcSEcCtD
Dextrothyroxine—Asthenia—Doxorubicin—urinary bladder cancer	0.000171	0.0011	CcSEcCtD
Dextrothyroxine—Pruritus—Doxorubicin—urinary bladder cancer	0.000168	0.00109	CcSEcCtD
Dextrothyroxine—Vomiting—Epirubicin—urinary bladder cancer	0.000163	0.00106	CcSEcCtD
Dextrothyroxine—Nausea—Methotrexate—urinary bladder cancer	0.000163	0.00106	CcSEcCtD
Dextrothyroxine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000163	0.00105	CcSEcCtD
Dextrothyroxine—Rash—Epirubicin—urinary bladder cancer	0.000162	0.00105	CcSEcCtD
Dextrothyroxine—Dermatitis—Epirubicin—urinary bladder cancer	0.000162	0.00105	CcSEcCtD
Dextrothyroxine—Headache—Epirubicin—urinary bladder cancer	0.000161	0.00104	CcSEcCtD
Dextrothyroxine—SLC7A5—Hemostasis—CREBBP—urinary bladder cancer	0.000158	0.00174	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—IGF1—urinary bladder cancer	0.000156	0.00172	CbGpPWpGaD
Dextrothyroxine—Nausea—Epirubicin—urinary bladder cancer	0.000153	0.000988	CcSEcCtD
Dextrothyroxine—SLCO1B1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000151	0.00166	CbGpPWpGaD
Dextrothyroxine—Vomiting—Doxorubicin—urinary bladder cancer	0.000151	0.000979	CcSEcCtD
Dextrothyroxine—SLCO4C1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.00015	0.00165	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.00015	0.00165	CbGpPWpGaD
Dextrothyroxine—Rash—Doxorubicin—urinary bladder cancer	0.00015	0.000971	CcSEcCtD
Dextrothyroxine—Dermatitis—Doxorubicin—urinary bladder cancer	0.00015	0.00097	CcSEcCtD
Dextrothyroxine—Headache—Doxorubicin—urinary bladder cancer	0.000149	0.000964	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—NQO1—urinary bladder cancer	0.000147	0.00162	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—RHOA—urinary bladder cancer	0.000143	0.00158	CbGpPWpGaD
Dextrothyroxine—Nausea—Doxorubicin—urinary bladder cancer	0.000141	0.000914	CcSEcCtD
Dextrothyroxine—THRA—Gene Expression—NCOR1—urinary bladder cancer	0.000141	0.00155	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—NCOR1—urinary bladder cancer	0.000141	0.00155	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000137	0.00151	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—ERCC2—urinary bladder cancer	0.000133	0.00146	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—ERCC2—urinary bladder cancer	0.000133	0.00146	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—GSTZ1—urinary bladder cancer	0.000127	0.00139	CbGpPWpGaD
Dextrothyroxine—SLCO1C1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000126	0.00138	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—GSTP1—urinary bladder cancer	0.000123	0.00135	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—IL2—urinary bladder cancer	0.00012	0.00132	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—GSTO2—urinary bladder cancer	0.00012	0.00132	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—NAT1—urinary bladder cancer	0.00012	0.00132	CbGpPWpGaD
Dextrothyroxine—THRB—Generic Transcription Pathway—MYC—urinary bladder cancer	0.00012	0.00132	CbGpPWpGaD
Dextrothyroxine—THRA—Generic Transcription Pathway—MYC—urinary bladder cancer	0.00012	0.00132	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000118	0.0013	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—TYMS—urinary bladder cancer	0.000114	0.00125	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—NCOR1—urinary bladder cancer	0.000113	0.00124	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—GSTM1—urinary bladder cancer	0.000113	0.00124	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—ESR1—urinary bladder cancer	0.000111	0.00122	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—ESR1—urinary bladder cancer	0.000111	0.00122	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—UGT2B7—urinary bladder cancer	0.00011	0.00121	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—GPX1—urinary bladder cancer	0.000108	0.00119	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—EP300—urinary bladder cancer	0.000108	0.00119	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—ERCC2—urinary bladder cancer	0.000106	0.00117	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—SRC—urinary bladder cancer	0.000105	0.00115	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000102	0.00112	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—PPARG—urinary bladder cancer	0.000101	0.00111	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—PPARG—urinary bladder cancer	0.000101	0.00111	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—MTHFR—urinary bladder cancer	9.97e-05	0.0011	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—CYP4B1—urinary bladder cancer	9.9e-05	0.00109	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—CREBBP—urinary bladder cancer	9.71e-05	0.00107	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—CREBBP—urinary bladder cancer	9.71e-05	0.00107	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—SLC19A1—urinary bladder cancer	9.35e-05	0.00103	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PRSS3—urinary bladder cancer	9.11e-05	0.001	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—KRAS—urinary bladder cancer	8.69e-05	0.000955	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—PPARG—urinary bladder cancer	8.08e-05	0.000889	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—CREBBP—urinary bladder cancer	7.77e-05	0.000854	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—TP53—urinary bladder cancer	7.72e-05	0.000849	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—HRAS—urinary bladder cancer	7.38e-05	0.000812	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	7.3e-05	0.000803	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—TYMP—urinary bladder cancer	7.28e-05	0.0008	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.99e-05	0.000769	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—NAT2—urinary bladder cancer	6.59e-05	0.000724	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—PTGS2—urinary bladder cancer	6.36e-05	0.000699	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—MYC—urinary bladder cancer	5.77e-05	0.000634	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—MYC—urinary bladder cancer	5.77e-05	0.000634	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—RRM2—urinary bladder cancer	5.69e-05	0.000625	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—PTEN—urinary bladder cancer	5.55e-05	0.00061	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—EP300—urinary bladder cancer	5.29e-05	0.000581	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—ENO2—urinary bladder cancer	5.27e-05	0.000579	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—HPGDS—urinary bladder cancer	5.27e-05	0.000579	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.23e-05	0.000575	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—GSTT1—urinary bladder cancer	5.11e-05	0.000561	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.03e-05	0.000553	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.78e-05	0.000526	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—NQO1—urinary bladder cancer	4.24e-05	0.000466	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.12e-05	0.000453	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.59e-05	0.000395	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—GSTP1—urinary bladder cancer	3.54e-05	0.000389	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.42e-05	0.000376	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	3.29e-05	0.000362	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	3.25e-05	0.000358	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	3.25e-05	0.000358	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	3.11e-05	0.000342	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	3.06e-05	0.000336	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	2.87e-05	0.000316	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	2.33e-05	0.000256	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	2.24e-05	0.000246	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	1.83e-05	0.000202	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	1.6e-05	0.000176	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—EP300—urinary bladder cancer	1.53e-05	0.000168	CbGpPWpGaD
